Kably AA, Ruiz AJ, Walters AF, García BCQ, Karchmer KS

Language: Spanish
References: 13
Page: 173-182
PDF size: 87.63 Kb.

ABSTRACT

Objective: To correlate estradiol and progesterone concentrations in luteal phase with pregnancy rates, and to determine the real value of estradiol administration during luteal phase support.
Patients and methods: In a prospective and comparative study, 69 patients who underwent IVF-ET program were divided in two groups: group 1 (n = 32) received luteal phase support only with progesterone and group 2, (n = 37) luteal phase support with estradiol and progesterone. Ovarian stimulation was made with recombinant FSH and GnRH analogues (agonists or antagonists) and 24 hours after oocyte retrieval we began luteal phase support: group 1 progesterone (in oily solution) 100 mg/day IM, and group 2 same progesterone doses plus 2 mg of estradiol valerianate. Statistical analysis was performed using students’ t- test and ROC curves.
Results: No statistical differences were observed in age, preovulatory estradiol levels, oocytes retrieved, fertilization rates, number of embryos transferred, or difficulty of embryo transfer among groups. The overall pregnancy rate was of 34.78% per cycle, no significant differences were observed among groups (37.5 vs 32.43%). We observed greater incidence of miscarriage in group 2 (4.35 vs 0%), without statistical significance. When comparing estradiol levels and pregnancy outcomes, higher levels were observed in the pregnancy group (403.3 vs 221.85 pg/mL) on day 7 post-transfer. Same results were reported for progesterone levels (107.04 vs 240.76). We determined that estradiol levels on day 7, higher than 244 pg/mL, could predict pregnancy with sensitivity of 58% and specificity of 70%, whereas progesterone levels greater than 108.6 ng/mL had specificity and sensitivity of 50 and 70%, respectively.
Conclusions: We couldn’t determine any advantage with estradiol supplementation during luteal phase support; however, measurement on day 7 of estradiol and progesterone allowed a greater predictive accuracy of pregnancy outcome.

REFERENCES

1. Penzias AS. Luteal phase support. Fertil Steril 2002;77:318-23.

2. Toner JP, Singer GA, Jones HW. Uterine receptivity alter ovarian stimulation for assisted reproduction. In: Gianaroli L, Campana A, Trounson AO, editors. Implantation in mamals. New York: Raven Press, 1993;pp:231-8.

3. Lessey BA, Yeh I, Castelbaum AJ, Fritz MA, Ilesanmi AO, Korzenimowski P. Endometrial progesterone markers of uterine receptivity in the window of implantation. Fertil Steril 1996;65:477-83.

4. Develioglu OH, Hsiu JG, Nikas G, Toner JP, Oehninger S, Jones HW. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril 1999;71:1040-7.

5. Forman RG, Eychenne B, Nesman C, Frydman R, Robel P. Assessing the early luteal phase in in vitro fertilization cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology. Fertil Steril 1989;51:310-6.

6. Licciardi FL, Kwiatkowski BSN, Noyes NL, Berkeley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterona for in vitro fertilization: a prospective randomized study. Fertil Steril 1999;71:614-8.

7. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization embryo transfer cycles. Fertil Steril 2000;73:761-6.

8. Sohn SH, Penzias AS, Emmi AM, et al. Administration of progesterone before oocyte retrieval negatively affects the implantation rate. Fertil Steril 1999;71:11-14.

9. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002;17:2287-99.

10. Stovall DW, Van Boris BJ, Sparks AE, Adams LM, Syrop CH. Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation. Fertil Steril 1998;70:1056-62.

11. Stelling JR, Barret CB, Penzias AS, Alper MM, Berger MJ, Oskowitz SP. Progesterone support in early IVF/GIFT pregnancies may not be neccesary (abstract 0-095). Presented in the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society Conjoint Annual Meeting, September 25-29, 1999. Toronto, Canada.

12. Kably AA, Ruiz AJ, Baptista PAA, Serulle TY, Quesnel GBC. Uso de antagonistas de GnRH (Cetrorelix en reproducción asistida: Primer informe en la literatura mexicana). Ginecol Obstet Mex 2002;70:424-30.

13. Akman MA, Erden HF, Bener F, Liu JE, Bahceci M. Can luteal phase estradiol levels predict the pregnancy outcome in in vitro fertilization cycles of good responders whose excess embryos yield blastocists? Fertil Steril 2002;77:638-9.